Actonel Once-a-Month/Actonel Once-a-Week Dosage & Drug Information

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Core Prescribing Info

Contents

Risedronate Na

Indications/Uses

Postmenopausal & established postmenopausal osteoporosis to reduce risk of vertebral & hip fractures, respectively. Actonel Once-a-Week Prevention of osteoporosis in postmenopausal women w/ increased risk of osteoporosis. To maintain or increase bone mass in postmenopausal women undergoing long-term (>3 mth) systemic corticosteroid treatment at doses of prednisone >7.5 mg/day or equiv. To increase bone mass in men w/ osteoporosis.

Dosage/Direction for Use

Osteoporosis Actonel Once-a-Month 150 mg once mthly, to be taken on the same date each mth. Actonel Once-a-Week 35 mg once wkly, to be taken on the same day each wk.

Administration

Should be taken on an empty stomach: Take at least 30 min before the 1st food/drink other than water. Take w/ plain water while in an upright position & avoid lying down for 30 min.

Contraindications

Hypersensitivity. Hypocalcaemia. Inability to stand or sit upright for at least 30 min. Actonel Once-a-Week Severe renal impairment (CrCl <30 mL/min). Pregnancy & lactation.

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BA07 - risedronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.

Regulatory Classification

POM

Presentation/Packing

Form

Actonel Once-a-Month FC tab 150 mg

Packing/Price

1's

Form

Actonel Once-a-Week FC tab 35 mg

Packing/Price

1's

Actonel Once-a-Month/Actonel Once-a-Week

risedronic acid

Manufacturer:

Balkanpharma Dupnitsa AD